These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 27604575
1. 99mTc-HYNIC-D4 Peptide: A New Small Radiolabeled Peptide for Non Small Cell Lung Tumor Targeting. Zahmatkesh MH, Abedi SM, Hosseinimehr SJ. Anticancer Agents Med Chem; 2017; 17(5):734-740. PubMed ID: 27604575 [Abstract] [Full Text] [Related]
2. Biological Evaluation of 99mTc-HYNIC-EDDA/tricine-(Ser)-D4 Peptide for Tumor Targeting. Kazemi Z, Zahmatkesh MH, Abedi SM, Hosseinimehr SJ. Curr Radiopharm; 2017 Aug 24; 10(2):123-130. PubMed ID: 28530534 [Abstract] [Full Text] [Related]
3. An improved 99mTc-HYNIC-(Ser)3-LTVSPWY peptide with EDDA/tricine as co-ligands for targeting and imaging of HER2 overexpression tumor. Khodadust F, Ahmadpour S, Aligholikhamseh N, Abedi SM, Hosseinimehr SJ. Eur J Med Chem; 2018 Jan 20; 144():767-773. PubMed ID: 29291444 [Abstract] [Full Text] [Related]
4. Preparation and biological evaluation of 99mTc-HYNIC-(Ser)3-D4 peptide for targeting and imaging of non-small-cell lung cancer. Haddad Zahmatkesh M, Abedi SM, Hosseinimehr SJ. Future Oncol; 2017 Apr 20; 13(10):893-905. PubMed ID: 28110557 [Abstract] [Full Text] [Related]
5. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging. Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V. Nucl Med Commun; 2014 Apr 20; 35(4):423-32. PubMed ID: 24335877 [Abstract] [Full Text] [Related]
6. Tricine co-ligand improved the efficacy of 99mTc-HYNIC-(Ser)3-J18 peptide for targeting and imaging of non-small-cell lung cancer. Shaghaghi Z, Abedi SM, Hosseinimehr SJ. Biomed Pharmacother; 2018 Aug 20; 104():325-331. PubMed ID: 29775901 [Abstract] [Full Text] [Related]
7. The Effect of A Hexanoic Acid Linker Insertion on the Pharmacokinetics and Tumor Targeting Properties of the Melanoma Imaging Agent 99mTc-HYNIC-cycMSH. Teixeira V, Fernández M, Oddone N, Zhang X, Gallazzi F, Cerecetto H, Gambini JP, Porcal W, Cabral P, Quinn TP. Anticancer Agents Med Chem; 2017 Aug 20; 17(8):1144-1152. PubMed ID: 27924732 [Abstract] [Full Text] [Related]
8. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals. Baishya R, Nayak DK, Chatterjee N, Halder KK, Karmakar S, Debnath MC. Chem Biol Drug Des; 2014 Jan 20; 83(1):58-70. PubMed ID: 23679852 [Abstract] [Full Text] [Related]
9. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma. Liu Z, Huang J, Dong C, Cui L, Jin X, Jia B, Zhu Z, Li F, Wang F. Mol Pharm; 2012 May 07; 9(5):1409-17. PubMed ID: 22452411 [Abstract] [Full Text] [Related]
10. 99mTc-(tricine)-HYNIC-Lys-FROP Peptide for Breast Tumor Targeting. Ahmadpour S, Noaparast Z, Abedi SM, Hosseinimehr SJ. Anticancer Agents Med Chem; 2018 May 07; 18(9):1295-1302. PubMed ID: 29521248 [Abstract] [Full Text] [Related]
11. Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer. Han Z, Xiao Y, Wang K, Yan J, Xiao Z, Fang F, Jin Z, Liu Y, Sun X, Shen B. J Nucl Med; 2018 Nov 07; 59(11):1686-1691. PubMed ID: 29777004 [Abstract] [Full Text] [Related]
12. 99m Tc-HYNIC-(Ser)3 -J18 peptide: A radiotracer for non-small-cell lung cancer targeting. Shaghaghi Z, Abedi SM, Hosseinimehr SJ. Chem Biol Drug Des; 2018 Jul 07; 92(1):1214-1220. PubMed ID: 29441688 [Abstract] [Full Text] [Related]
13. 99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo. King R, Surfraz MB, Finucane C, Biagini SC, Blower PJ, Mather SJ. J Nucl Med; 2009 Apr 07; 50(4):591-8. PubMed ID: 19289435 [Abstract] [Full Text] [Related]
14. Synthesis and evaluation of Tc-99m-labeled RRL-containing peptide as a non-invasive tumor imaging agent in a mouse fibrosarcoma model. Kim DW, Kim WH, Kim MH, Kim CG. Ann Nucl Med; 2015 Nov 07; 29(9):779-85. PubMed ID: 26179963 [Abstract] [Full Text] [Related]
15. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer. Liu S, Hsieh WY, Jiang Y, Kim YS, Sreerama SG, Chen X, Jia B, Wang F. Bioconjug Chem; 2007 Nov 07; 18(2):438-46. PubMed ID: 17341108 [Abstract] [Full Text] [Related]
16. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41. Welling MM, Visentin R, Feitsma HI, Lupetti A, Pauwels EK, Nibbering PH. Nucl Med Biol; 2004 May 07; 31(4):503-9. PubMed ID: 15093821 [Abstract] [Full Text] [Related]
17. [Synthesis and animal imaging of 99mTc-hydrazinonicotinamide-folate as a new folate receptor-targeted tumor imaging agent]. Liu LQ, Wang SZ, Li F, Teng B, Wang KZ, Qiu FC. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec 07; 28(6):786-9. PubMed ID: 17260467 [Abstract] [Full Text] [Related]
18. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression. Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R. Nucl Med Biol; 2006 Nov 07; 33(8):945-52. PubMed ID: 17127166 [Abstract] [Full Text] [Related]
19. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe 99mTc-HYNIC-H6F in Breast Cancer Mouse Models. Li L, Wu Y, Wang Z, Jia B, Hu Z, Dong C, Wang F. J Nucl Med; 2017 May 07; 58(5):821-826. PubMed ID: 28104744 [Abstract] [Full Text] [Related]
20. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent. Zhang X, Chen X. Appl Radiat Isot; 2007 Jan 07; 65(1):70-8. PubMed ID: 17011200 [Abstract] [Full Text] [Related] Page: [Next] [New Search]